Terms: = Brain cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
147 results:
1. DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment.
Song M; Wang T; Liu T; Lei T; Teng X; Peng Q; Zhu Q; Chen F; Zhao G; Li K; Qi L
Biomed Pharmacother; 2024 May; 174():116470. PubMed ID: 38565061
[TBL] [Abstract] [Full Text] [Related]
2. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
3. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
Shirai Y; Ueno T; Kojima S; Ikeuchi H; Kitada R; Koyama T; Takahashi F; Takahashi K; Ichimura K; Yoshida A; Sugino H; Mano H; Narita Y; Takahashi M; Kohsaka S
J Neurooncol; 2024 Mar; 167(1):75-88. PubMed ID: 38363490
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
5. Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Wildiers H; Armstrong A; Cuypere E; Dalenc F; Dirix L; Chan S; Marme F; Schröder CP; Huober J; Duhoux FP; Vuylsteke P; Jager A; Brain E; Kuemmel S; Pápai Z; Menke-van der Houven van Oordt CW; Perjesi L; Mueller C; Brignone C; Triebel F
Clin Cancer Res; 2024 Feb; 30(3):532-541. PubMed ID: 37939105
[TBL] [Abstract] [Full Text] [Related]
6. Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT.
Donoghue K; Boniface S; Brobbin E; Byford S; Coleman R; Coulton S; Day E; Dhital R; Farid A; Hermann L; Jordan A; Kimergård A; Koutsou ML; Lingford-Hughes A; Marsden J; Neale J; O'Neill A; Phillips T; Shearer J; Sinclair J; Smith J; Strang J; Weinman J; Whittlesea C; Widyaratna K; Drummond C
Health Technol Assess; 2023 Oct; 27(22):1-88. PubMed ID: 37924307
[TBL] [Abstract] [Full Text] [Related]
7. Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.
Kang HW; Kim JH; Lee DE; Lee YS; Kim MJ; Kim HS; Fang S; Lee BE; Lee KJ; Yoo J; Kim HJ; Park JS
Cancer Biol Ther; 2023 Dec; 24(1):2272334. PubMed ID: 37917550
[TBL] [Abstract] [Full Text] [Related]
8. Current treatment landscape of HR+/HER2- advanced breast cancer in the Nordics: a modified Delphi study.
Geisler J; Karihtala P; Tuxen M; Valachis A; ; Holm B
Acta Oncol; 2023 Dec; 62(12):1680-1688. PubMed ID: 37713138
[TBL] [Abstract] [Full Text] [Related]
9. Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B; Hong MH; Shin SH; Heo SG; Kim JE; Ahn HK; Lee YG; Park KU; Yun T; Lee KW; Kim SB; Lee SC; Kim MK; Cho SH; Oh SY; Park SG; Hwang S; Nam BH; Kim S; Kim HR; Yun HJ;
J Clin Oncol; 2024 Feb; 42(5):507-517. PubMed ID: 37699162
[TBL] [Abstract] [Full Text] [Related]
10. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma.
Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
[TBL] [Abstract] [Full Text] [Related]
11. cdk4/6 Inhibition Sensitizes Intracranial Tumors to PD-1 Blockade in Preclinical Models of brain Metastasis.
Nayyar N; de Sauvage MA; Chuprin J; Sullivan EM; Singh M; Torrini C; Zhang BS; Bandyopadhyay S; Daniels KA; Alvarez-Breckenridge C; Dahal A; Brehm MA; Brastianos PK
Clin Cancer Res; 2024 Jan; 30(2):420-435. PubMed ID: 37611074
[TBL] [Abstract] [Full Text] [Related]
12. A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.
Tran S; Thomas A; Aliouat I; Karachi C; Lozano F; Mokhtari K; Dehais C; Feuvret L; Carpentier C; Giry M; Doukani A; Lerond J; Marie Y; Sanson M; Idbaih A; Carpentier A; Hoang-Xuan K; Touat M; Capelle L; Bielle F
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12928. PubMed ID: 37503540
[TBL] [Abstract] [Full Text] [Related]
13. A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via cdk4/6 Inhibition.
Wang Y; Li Y; Liu D; Zheng D; Li X; Li C; Huang C; Wang Y; Wang X; Li Q; Xu J
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446710
[TBL] [Abstract] [Full Text] [Related]
14. Pediatric Precision Medicine at the National cancer Center Japan: Prospective Genomic Study of Pediatric Patients with cancer as Part of the TOP-GEAR Project.
Tao K; Yamazaki F; Kubo T; Sunami K; Kumamoto T; Arakawa A; Sugiyama M; Watanabe Y; Nakajima M; Shirakawa N; Tanimura K; Koyama T; Hirata M; Sudo K; Tanabe N; Watanabe T; Yoshida T; Kitami M; Yoshida A; Yatabe Y; Nakano Y; Ohira M; Kamijo T; Nakazawa A; Kato M; Ichimura K; Kohno T; Yamamoto N; Hishiki T; Ichikawa H; Ogawa C
JCO Precis Oncol; 2023 Jul; 7():e2200266. PubMed ID: 37410973
[TBL] [Abstract] [Full Text] [Related]
15. Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/ATR Pathway in Androgen-Independent Prostate cancer.
Kim HY; Lee SW; Choi SK; Ashim J; Kim W; Beak SM; Park JK; Han JE; Cho GJ; Ryoo ZY; Jeong J; Lee YH; Jeong H; Yu W; Park S
Am J Chin Med; 2023; 51(5):1309-1333. PubMed ID: 37385965
[TBL] [Abstract] [Full Text] [Related]
16. cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined treatment.
Giordano F; D'Amico M; Montalto FI; Malivindi R; Chimento A; Conforti FL; Pezzi V; Panno ML; Andò S; De Amicis F
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373242
[TBL] [Abstract] [Full Text] [Related]
17. HR+/HER2- Advanced Breast cancer treatment in the First-Line Setting: Expert Review.
Jerzak KJ; Bouganim N; Brezden-Masley C; Edwards S; Gelmon K; Henning JW; Hilton JF; Sehdev S
Curr Oncol; 2023 Jun; 30(6):5425-5447. PubMed ID: 37366894
[TBL] [Abstract] [Full Text] [Related]
18. A novel cdk4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.
Zuo P; Li Y; Wang T; Lin X; Wu Z; Zhang J; Liao X; Zhang L
J Neurooncol; 2023 May; 163(1):159-171. PubMed ID: 37133743
[TBL] [Abstract] [Full Text] [Related]
19. Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to cdk4/6 inhibition.
Vo T; Balderson B; Jones K; Ni G; Crawford J; Millar A; Tolson E; Singleton M; Kojic M; Robertson T; Walters S; Mulay O; Bhuva DD; Davis MJ; Wainwright BJ; Nguyen Q; Genovesi LA
Genome Med; 2023 May; 15(1):29. PubMed ID: 37127652
[TBL] [Abstract] [Full Text] [Related]
20. Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
Wu S; Liu Y; Williams M; Aguilar C; Ramirez AG; Mesa R; Tomlinson GE
PLoS One; 2023; 18(4):e0278354. PubMed ID: 37022991
[TBL] [Abstract] [Full Text] [Related]
[Next]
